ArticleAnnals of medicine and surgery (2012)2026
Toward a deeper and more comprehensive understanding of neurological symptoms related to Allgrove syndrome: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Allgrove syndrome (AS) is a rare autosomal recessive disorder caused by Case presentation: We report a 13-year-old boy with AS on oral hydrocortisone who presented with recurrent vomiting for 1 month. Neurological examination revealed below-average intellectual function, decreased muscle bulk, mild weakness, bilateral hyperreflexia, wide-based ataxic gait, intention tremor, dysarthria, and positive finger-nose test. Cranial nerves and sensation were intact. Laboratory investigations showed elevated ACTH due to poor hydrocortisone absorption, and endoscopy confirmed achalasia. He was switched to intravenous hydrocortisone and underwent Heller myotomy with Nissen fundoplication, resulting in resolution of vomiting and normalization of ACTH, though neurological symptoms persisted. Clinical discussion: AS often presents first with alacrima, followed by achalasia, causing dysphagia and vomiting, and adrenal insufficiency developing in childhood, which can be life-threatening. Neurological manifestations may include ataxia, tremor, hyperreflexia, and cognitive impairment. Our case highlights the impact of achalasia on hydrocortisone absorption and the need for early multidisciplinary intervention. Conclusion: Early recognition, long-term follow-up, and proper care are crucial to prevent adrenal crises and manage neurological complications, improving outcomes and quality of life in affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.